JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002041200 on September 5, 2000

J. Biol. Chem., Vol. 275, Issue 47, 36676-36682, November 24, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/47/36676    most recent
M002041200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, W.
Right arrow Articles by DeLisle, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, W.
Right arrow Articles by DeLisle, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calreticulin Modulates Capacitative Ca2+ Influx by Controlling the Extent of Inositol 1,4,5-Trisphosphate-induced Ca2+ Store Depletion*

Wen XuDagger , Frank J. Longo§, Mary R. Wintermantel, Xueying JiangDagger , Robert A. Clark||, and Sylvain DeLisleDagger **

From the Dagger  Veterans Affairs Medical Center and Departments of Medicine and Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, the § Department of Anatomy,  University of Iowa College of Medicine, Iowa City, Iowa 52242, and the || Department of Medicine, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, Texas 78230

Received for publication, March 10, 2000, and in revised form, September 5, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Calreticulin (CRT) is a highly conserved Ca2+-binding protein that resides in the lumen of the endoplasmic reticulum (ER). We overexpressed CRT in Xenopus oocytes to determine how it could modulate inositol 1,4,5-trisphosphate (InsP3)-induced Ca2+ influx. Under conditions where it did not affect the spatially complex elevations in free cytosolic Ca2+ concentration ([Ca2+]i) due to InsP3-induced Ca2+ release, overexpressed CRT decreased by 46% the Ca2+-gated Cl- current due to Ca2+ influx. Deletion mutants revealed that CRT requires its high capacity Ca2+-binding domain to reduce the elevations of [Ca2+]i due to Ca2+ influx. This functional domain was also required for CRT to attenuate the InsP3-induced decline in the free Ca2+ concentration within the ER lumen ([Ca2+]ER), as monitored with a "chameleon" indicator. Our data suggest that by buffering [Ca2+]ER near resting levels, CRT may prevent InsP3 from depleting the intracellular stores sufficiently to activate Ca2+ influx.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Since it was first isolated a quarter of a century ago (1), the protein calreticulin (CRT)1 has been identified in a great variety of cells, implying an essential biological activity (2). Although CRT may be critical for cardiac development (3), to date, the nature of the cellular function of CRT remains poorly understood. CRT binds to steroid receptors (4, 5) and to integrins (6, 7) and thus could modulate gene transcription (8, 9) or cellular adhesion (2, 10-12). To reach these targets, however, CRT would need to be present both in the nucleus and the cytosol. Although CRT has been reported in these cellular compartments (see Refs. 2 and 10 but also see Ref. 13), the bulk of the protein clearly resides elsewhere, i.e. inside the endoplasmic reticulum (ER). Within the ER lumen, CRT may assist in the folding and assembly of glycoproteins (14-17). ER CRT may also act as a repository of readily releasable Ca2+, with each mole of CRT binding as many as 20-25 mol of Ca2+. Since Ca2+ release from the ER is controlled mainly by the second messenger inositol 1,4,5-trisphosphate (InsP3), CRT emerges as a potential regulator of this ubiquitous signal transduction pathway.

The InsP3-induced Ca2+ signal has two main components, the release of Ca2+ from the intracellular stores (InsP3-induced Ca2+ release, or IICR) and the influx of Ca2+ across the plasma membrane (InsP3-induced Ca2+ influx, or IICI). IICR starts when InsP3 binds to its intracellular receptor (InsP3R), a ligand-gated Ca2+ channel that traverses the lipid membrane surrounding the ER. The resulting discharge of ER Ca2+ into the cytosol is often spatially complex, with periodic focal release of Ca2+ actively spreading to the rest of the cell through mechanisms that remain incompletely understood (18). IICI commonly follows IICR, thereby allowing cells to recharge their internal stores. Stimulation of Ca2+ influx appears closely linked to the depletion of the intracellular Ca2+ stores, a relationship known as capacitative Ca2+ entry. We do not yet understand how Ca2+ store depletion stimulates Ca2+ influx. Store depletion could communicate with the plasma membrane through a diffusible messenger (19, 20), through secretion-like vesicular docking (21, 22), or through protein-protein interactions that may involve the InsP3R itself (23-25).

Even though Ca2+ storage was the first function ascribed to CRT (1), we do not yet know what role, if any, CRT plays in the regulation of the InsP3-induced Ca2+ signal. Whereas gene knock-out experiments indicate that CRT is not essential for IICR (11), overexpression of CRT has been associated with a decrease in the magnitude of IICI in mammalian cell lines (26-28). These results have prompted the hypothesis that CRT reduces capacitative Ca2+ entry by buffering the free Ca2+ concentration within the ER lumen ([Ca2+]ER) above the levels required to trigger capacitative Ca2+ influx. In this work, our objective was to put this hypothesis to a rigorous test by directly measuring [Ca2+]ER in a widely used model cell, the Xenopus oocyte. Our data indicate that CRT requires its high capacity Ca2+-binding domain both to attenuate the InsP3-induced decrease in [Ca2+]ER and to reduce the elevations of [Ca2+]i due to IICI. The ability of CRT to buffer [Ca2+]ER may thus be functionally relevant to the InsP3-induced Ca2+ signal.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

CRT and CRT Deletion Mutant Expression Vectors-- We inserted the CRT cDNA cloned from the HL60 human leukemia cell line (29) between the PstI and SalI sites of the pMT3 plasmid vector (30). We used the polymerase chain reaction (PCR) to build CRT mutants lacking functional domains. To remove the C-domain (CRT-Delta C), we amplified the N and P domains of CRT (amino acids 2-315) and added a KDEL ER retrieval sequence at the C terminus (primers 1 and 2). The PCR fragment was digested with MluI and EcoRI and inserted between those sites in a modified pMT3. For the construct lacking the P-domain (CRT-Delta P), we amplified the N-domain (amino acids 2-197, primers 1 and 3) and the C-domain (amino acids 316-401, primers 4 and 5) separately. The PCR fragments were then respectively digested with MluI/SpeI and with SpeI/EcoRI and ligated between the MluI and the EcoRI sites of pMT3. Primers sequence were as follows, from 5' to 3': primer 1, GTCACGCGTCTGCTATCCGTGCCGCTG; primer 2, CGGAATTCTCAGAGTTCATCCTTGCCCAGCACGCCAAAGTTATC; primer 3, CGTACTAGTTTCCAAGGAGCCGGAC; primer 4, GTCACTAGTCTGGATCTCTGGCAAGTCAAGTCTGG; primer 5, CGGAATTCTCATTCGAGTCTCACAGAGAC.

cDNA-directed Protein Expression and Western Blotting-- We prepared stage V-VI oocytes from albino Xenopus laevis and injected the DNA constructs into the nucleus as described previously (31, 32). Oocyte microsome purification, protein solubilization, SDS-polyacrylamide gel electrophoresis, and transfer to nitrocellulose were as outlined in the past (33). For immunoblotting, we used a polyclonal antibody raised against the full-length recombinant HL60 CRT (29). We performed all our functional studies 48-72 h after plasmid injection, when CRT expression level was found to be maximal in preliminary experiments.

Electrophysiology-- We assayed [Ca2+]i by measuring Ca2+-activated Cl- currents with the two-electrode voltage clamp technique (31). This assay has been validated using Ca2+-sensitive electrodes (34-36) and fluorescent Ca2+ indicators (31, 37-41). We performed intracellular injections and calibrated the injection pipettes as we had done in the past (31). Bath solution contained (in mM) the following: 116 NaCl, 2.0 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, pH 7.4. In the experiments where Ca2+ stores were to be irreversibly depleted, oocytes were incubated with 2 µM thapsigargin (Calbiochem) for 3 h (42, 43). Cells were then microinjected with 4 nmol of either EGTA (Sigma) or 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (Molecular Probes, Eugene, OR) to prevent [Ca2+]i elevations from activating the Ca2+-activated Cl- currents. Cells were then put into a bath solution (in mM, either 70 MgCl2 or 70 CaCl2, 10 HEPES, pH 7.2), and the inward Ca2+ currents resulting from the influx of extracellular Ca2+ were directly measured with the two-electrode voltage clamp technique (43).

To ensure that the individual cells studied electrophysiologically expressed the protein of interest, plasmid cDNA coding for CRT or CRT mutants was co-injected with pMT3-sg25 (20:1 concentration ratio), a vector coding for an enhanced green fluorescent protein (GFP). We performed electrophysiology experiments on those live cells that showed the highest GFP fluorescence.

Monitoring [Ca2+]ER with Fluorescence Resonance Energy Transfer (FRET)-- We excised the "yellow chameleon-3er or -4er" (3er or 4er) cDNAs (gifts from Dr. Roger Y. Tsien, Howard Hughes Medical Institute, University of California, San Diego, CA) from the pcDNA vector and inserted them between the NotI and EcoRI sites of pMT3. The 3er/4er Ca2+ indicators contain two mutated GFP yielding cyan (CFP) or yellow (YFP) fluorescence (44). The amino acids linking YFP to CFP include the sequences for CaM and for the M13 CaM-binding peptide. Upon Ca2+ binding, CaM enfolds M13 thereby creating FRET between YFP and CFP. To enable measurements of the relatively high [Ca2+]ER, CaM sequences of 3er and 4er were modified to lower their affinity for Ca2+ (44). 3er and 4er also include sequences from CRT that allow their retrieval into the ER lumen. To measure FRET, we illuminated oocytes expressing 3er/4er (lambda  = 440 ± 15 nm, DeltaRam monochromator, Photon Technology International, Monmouth Junction, NJ, 455DCLP dichroic mirror) and recorded the emission intensity at two wavelengths, 485 and 535 nm, using separate photomultiplier tubes (520DCLP dichroic mirror, D485/40M and D5356/30M emission filters, Chroma Technology, Brattleboro, VT). If we could not calibrate 3er in vivo, we could nevertheless use the 535/485 fluorescence ratio to compare [Ca2+]ER among cells submitted to identical illumination. In these experiments, the gains of the photomultiplier tubes were carefully matched, and neutral black levels were determined experimentally (45).

Immunolocalization-- Oocyte cryosections (5 µm thick) were incubated for 30 min first with 1/200-1/500 dilutions of the anti-CRT antibody and then with a fluorescein isothiocyanate-conjugated anti-rabbit secondary antibody, and examined with a fluorescence microscope as described before (32). For ultrastructural studies, cryosections (10 µm thick) were fixed, incubated for 1 h in anti-CRT antibody and then overnight in anti-rabbit antibody conjugated to 5 nm gold particles (Janssen Life Sciences Products, Piscataway, NJ), and prepared for examination under in a Hitachi 7000 electron microscope (Hitachi Ltd., Tokyo) as described previously (32).

45Ca2+ Uptake-- Oocytes injected either with pMT3 alone or with pMT3-CRT were incubated in 45Ca2+-containing solution (8 µCi/ml). 45Ca2+-related counts increased gradually and reached a plateau at 36-48 h, indicating equilibration across the Ca2+-binding compartments of the oocyte. After a 72-h incubation period, chosen to ensure isotopic equilibrium, intact oocytes were washed 5 times in cold solution and individually transferred to scintillation vials for counting. Alternatively, the washed oocytes were combined and homogenized, and their microsomes were purified and recovered on filter paper prior to counting, as per our previously published methodology (33).

Calcium Imaging and Confocal Microscopy-- Oocytes were injected with either fluo 3 alone (250 µM), Ca2+ orange alone (250 µM), or a mixture of fluo 3 (100 µM) and fura red (300 µM) (Molecular Probes). They were then stimulated with a 30-nl droplet of Ins(2,4,5)P3 (10 µM) and the resulting fluorescence visualized on a confocal microscope as described previously (46). Ca2+ wave amplitude, velocity, frequency, as well as rates of rise/decrease in [Ca2+]i at the wave fronts were determined as detailed before (32). To compare [Ca2+]i between different cells using visible excitation wavelengths, we ratioed the simultaneously measured fluorescence signal from fluo 3 and fura red (45). The detailed validation of this technique in the oocyte has been previously published (32). Image analysis was performed using the NIH Image version 1.61 software.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Overexpression of CRT in Xenopus Oocytes-- On a Western blot of microsomal proteins from which we have previously purified CRT, the ER lumenal protein calsequestrin and the InsP3R (33, 47), an anti-CRT antibody (29), labeled an ~60-kDa protein (Fig. 1, 1st lane). After injection with pMT3-CRT, the density of this band increased significantly, indicating overexpression of CRT (Fig. 1, 2nd lane). Immunostaining revealed reticular fluorescence that increased from the vegetal to the animal pole of the cell in a pattern similar to that of control cells, but much brighter (Fig. 2). We observed a similar fluorescence pattern with overexpressed InsP3R (32). Under electron microscopy using a gold-labeled secondary antibody targeted at an anti-CRT primary antibody, the gold particles were found in association with membranous cisternae most likely representing elements of the ER (Fig. 3). There was no label associated with mitochondria or with other organelles. Given CRT's ER retrieval sequences and lack of hydrophobic regions that can stretch across lipid bilayers, our data suggest that CRT is overexpressed within the ER lumen.


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 1.   Overexpression of CRT in Xenopus oocyte. A, each lane represents an identical amount of solubilized microsomal protein submitted to SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and blotted with a polyclonal antibody against HL60-CRT. When compared with controls (1st lane), CRT (bands facing the closed arrow) was increased in cells microinjected with pMT3-CRT (2nd lane). Note the appearance of new bands (open arrow) in cells microinjected with pMT3-CRT-Delta P (doublet in 3rd lane) or pMT3-CRT-Delta C (4th lane).


View larger version (142K):
[in this window]
[in a new window]
 
Fig. 2.   Localization of CRT by immunofluorescence. Anti-CRT staining shows a marked increase in fluorescence signal in CRT-expressing oocytes (lower panels) compared with controls (upper panels). The reticular pattern, the subcortical columns (arrowheads), and the decreasing fluorescence from the animal pole (A and D) to the equatorial region (B and E) and to the vegetal pole (C and F) is typical of the ER distribution in oocytes. Oocytes exposed only to the secondary antibody were negative.


View larger version (116K):
[in this window]
[in a new window]
 
Fig. 3.   Localization of CRT by immunogold staining. Electron microscopy at the animal pole of an oocyte overexpressing CRT is indicated. Gold particles targeted against an anti-CRT antibody are associated with cisternae of endoplasmic reticulum (arrowheads).

CRT Decreases the [Ca2+]i Elevations Due to Ca2+ Influx-- To investigate the effect of CRT overexpression on Ca2+ influx, we microinjected either pMT3 or pMT3-CRT in oocytes. We then stimulated the cells with a saturating concentration of InsP3 (10 nl of 10-3 M solution or a 10 µM average concentration) and assayed [Ca2+]i by measuring Ca2+-gated Cl- current with the two-electrode voltage clamp technique. The Ca2+-gated Cl- current reflects [Ca2+]i just beneath the plasma membrane (48, 49), where it is most likely to be affected by Ca2+ influx. The assay integrates the submembranous [Ca2+]i changes across the entire surface of the plasma membrane, thereby maximizing our ability to detect changes in the magnitude of Ca2+ influx. In control cells, microinjection of InsP3 (10-3 M in the pipette) causes a biphasic response; there is a short initial increase in [Ca2+]i followed by a slow increase (Fig. 4A). The fast initial component of the response, which is not affected by the removal of extracellular Ca2+, is due to the release of Ca2+ from the intracellular stores (50, 51). In contrast, the slow component of the response can be inhibited by decreasing the extracellular Ca2+ concentration or by adding inorganic Ca2+ channel blockers (Mn2+, Ni2+, and La3+) to the bath and thus depends on Ca2+ influx (50-52). Although the magnitude of the Cl- currents due to IICR was similar to that of control cells (272 ± 28 nA in CRT versus 247 ± 23 nA in controls, n = 31 pairs of cells), the Ca2+ influx-dependent Cl- current was reduced almost in half in cells overexpressing CRT (77 ± 15 nA versus 143 ± 19 nA in controls, n = 31 matched pairs of cells, one of which is shown in Fig. 4, p < 0.001). These results, which are consistent with those obtained in mammalian cell lines (26, 27), indicate that CRT reduces the rise in [Ca2+]i due to Ca2+ influx. Direct measurements of whole cell current due to Ca2+ or Ba2+ entry have indicated that the Ca2+-gated Cl- current assay has a high sensitivity for measuring the magnitude of Ca2+ influx (22, 43). Thus, our results suggest that CRT overexpression reduces the rate at which extracellular Ca2+ enters the cell.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of CRT overexpression on the [Ca2+]i elevations due to Ca2+ influx. Successive experiments performed in a control cell (A) and a CRT-overexpressing cell (B) are shown. Each tracing represent the Cl- current response to an intracellular injection of Ins(1,4,5)P3 (arrow) as a function of time. Downward deflection (inward current) represents an increase in [Ca2+]i. Note that the slow component of the biphasic response in the control cell (A) can be inhibited by lowering the extracellular [Ca2+] from 6 to 0.1 mM (bar) and is therefore due to Ca2+ influx. The Cl- current due to Ca2+ influx is markedly diminished in the cell overexpressing CRT (B).

CRT Attenuates the InsP3-induced Decline in [Ca2+]ER-- In the context of capacitative Ca2+ entry, CRT could reduce IICI by buffering [Ca2+]ER to levels above those required to stimulate Ca2+ influx. Because neither the precise value of [Ca2+]ER nor the degree to which CRT contributes to the overall Ca2+-binding properties of the ER lumenal milieu is presently known, we could not confidently predict if/how altered CRT levels affect [Ca2+]ER. To test this hypothesis, we therefore monitored [Ca2+]ER directly with an ER-targeted FRET indicator, chameleon 3er (3er) (44). At base line, the 535/485 fluorescence emission ratios in cells co-expressing 3er and CRT were similar to the ratios found in cells expressing 3er alone (1.08 ± 0.07 versus 1.09 ± 0.07, n = 16 matched cell pairs). Because the 3er indicator saturates at [Ca2+] in excess of 100 µM (44), we repeated the experiments, this time expressing a lower affinity indicator, 4er, that could report [Ca2+]ER between 10-4 and 10-2 M. The 535/485 ratios in cells co-expressing 4er and CRT were also similar to the ratios found in control cells (0.79 ± 0.04 versus 0.81 ± 0.05, n = 6 matched cell pairs). These data indicate that overexpressed CRT does not measurably change the resting [Ca2+]ER.

When microinjected with InsP3 (10-4 M in the pipette), the control oocyte showed a reversible decrease in the 535/485 fluorescence emission ratio of 3er, indicating a decrease in [Ca2+]ER (see Fig. 5A). As shown in Fig. 5B, cells co-expressing CRT reached a smaller InsP3-induced decline in the 535/485 emission ratio of 3er than did control cells (2.8 ± 0.8% versus 8.3 ± 0.6%, n = 16 matched cell pairs, p < 10-5), suggesting that CRT overexpression attenuates the InsP3-induced decline in [Ca2+]ER.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of CRT-overexpression on [Ca2+]ER. A, in a cell expressing the 3er FRET indicator and injected with InsP3 (arrow), the emission intensity increases at 485 nm (upper tracing, left axis) and decreases at 535 nm (middle tracing, left axis). Thus, the 535/485 fluorescence intensity ratio (lower tracing, right axis) decreases reversibly as function of time, indicating a decrease in [Ca2+]ER. B, peak decline in the 535/485 ratio of 3er due to an injection of InsP3 is more pronounced in cells expressing 3er alone (closed circles on the left) than in cells co-expressing 3er and CRT (open circles on the right). Base-line 535/485 ratio was normalized to 1.

The ability of CRT to maintain [Ca2+]ER near resting levels uncouples Ca2+ store depletion from intracellular InsP3 levels in a novel way; unlike the Ca2+ ATPase inhibitor thapsigargin, which deplete the stores at basal InsP3 levels, overexpressed CRT prevented store depletion despite high InsP3 levels. Recent evidence suggests that the role played by the InsP3R in Ca2+ influx extends beyond simply lowering [Ca2+]ER (25). In this context, our direct measurements of [Ca2+]ER serve as a reminder that store depletion is required to stimulate Ca2+ influx and that elevated InsP3, by itself, is not sufficient.

Effect of CRT on IICR-- The simplest mechanism by which CRT could prevent the InsP3-induced decrease in [Ca2+]ER would be to inhibit IICR. However, our data suggested that this was not the case with saturating concentrations of InsP3; in the cells where CRT had decreased the Ca2+ influx-related Cl- current, there was no change in the initial Cl- currents due to IICR. Yet, in oocytes, CRT was previously reported to inhibit the Ca2+ waves triggered by sub-maximal concentrations of Ins(1,4,5)P3 (53). To test the effect of CRT on the spatial aspects of IICR under experimental conditions where it could reduce Ca2+ influx, we microinjected sub-maximal InsP3 concentrations into oocytes loaded with fluorescent Ca2+ indicators and visualized the resulting Ca2+ waves with a confocal microscope (46, 54). As shown in Fig. 6A, overexpression of CRT did not affect the amplitude, the velocity, or the frequency of the repetitive Ca2+ waves. To determine whether an increase in CRT levels changes the rate at which Ca2+ is released from intracellular stores, we examined the fluorescence intensity along a narrow linear path running perpendicular to the wave front; by multiplying the average slope of the increasing fluorescence values at the wave front (partial F/partial distance) by the instantaneous speed of the wave (partial  distance/partial time), we obtained the rate at which [Ca2+] rises at the wave front (partial F/partial time) (32). The rate of rise in fluorescence intensity over base line at the wave front was 38 ± 4% s-1 for control cells and 36 ± 2% s-1 for CRT-expressing cells (19 wave pairs were randomly chosen from 8 CRT/control cell pairs) suggesting a similar rate of Ca2+ release at the wave front (Fig. 6A). Although our results that CRT expression did not change the amplitude of the Ca2+ waves agree with those of Camacho and Lechleiter (53), we did not find that CRT decreases Ca2+ waves frequency. Many reasons could explain this difference. 1) We studied our cells 2-3 days after DNA injection, whereas Camacho's group studied theirs after 5-7 days. Although we studied our cells at a time when CRT was already expressed maximally and could reduce Ca2+ influx, we may have missed a time-dependent effect of CRT on the Ca2+ waves. 2) We studied only those cells that had proven exogenous protein expression and that had preserved plasma membrane electrical resistance. Camacho and Lechleiter (53) did not screen individual cells for protein overexpression or for plasma membrane electrical integrity. Thus, the reported decrease in the frequency of Ca2+ waves could not be unequivocally ascribed to an increase in CRT levels and may have been restricted to cells that were electrically leaky. 3) Most of the experimental data reported by Camacho and Lechleiter (53) were obtained in cells co-expressing the Ca2+-ATPase SERCA2b. In a later publication, the same group (55) reported that CRT-Delta C, which had inhibited the Ca2+ waves in cells co-expressing SERCA2b, had no effect on the Ca2+ waves in cells co-expressing SERCAs lacking an ER-lumenal glycosylation site. Thus, their results may mainly reflect an interplay between CRT and SERCA2b (55). Our results suggest that under conditions where an increased amount of CRT within the ER can reduce the InsP3-induced decline in [Ca2+]ER, CRT does not materially affect the mechanisms that initiate and propagate Ca2+ waves. Thus, CRT does not appear to diminish the InsP3-induced decline in [Ca2+]ER by inhibiting IICR.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of CRT overexpression on InsP3-induced Ca2+ waves and on Ca2+ uptake. Each bar represent the mean value of a measured parameter in CRT-overexpressing cells as a percent of control values. A, effect of CRT overexpression on InsP3-induced Ca2+ waves. The five parameters measured were (bars from left to right) as follows: 1) basal [Ca2+] before the passage of a Ca2+ wave; 2) peak [Ca2+] at the wave front; 3) instantaneous wave velocity; 4) frequency of the repetitive waves; 5) rate of Ca2+ release at the wave front. B, effect of CRT overexpression on Ca2+ reuptake/extrusion. The three parameters measured were the rate at which peak [Ca2+]i decreases following either the passage of a Ca2+ wave (1st bar) or an intracellular injection of CaCl2 (2nd bar) and the ATP-dependent 45Ca2+ accumulation into purified microsomes (3rd bar). The number of Ca2+ wave pairs compared across 8-11 matched cell pairs is indicated above the 5 bars of A and the 1st bar of B. Number of experimental pairs is indicated above the 4th bar of A and the 2nd and 3rd bars of B. Asterisk indicates statistically significant difference compared with controls (p < 0.05). Except for slowing the return to basal [Ca2+]i following a Ca2+ injection, CRT overexpression affected none of the measured parameters.

Effect of CRT on Ca2+ Uptake and/or Ca2+ Extrusion-- CRT could blunt the InsP3-induced decrease in [Ca2+]ER if it accelerated the reuptake of cytosolic Ca2+ into the ER lumen. To investigate this alternative hypothesis, we first estimated the rate at which [Ca2+]i returns to base line following the passage of a Ca2+ wave front using an analysis similar to that described in the preceding paragraph. We found that the rate of [Ca2+]i decline was not accelerated in cells expressing CRT (Fig. 6B). Next, we scanned the site of an intracellular injection of CaCl2 (1 nl, 50 mM) with a single laser line (scanning rate = 500 Hz) in oocytes loaded with fluo 3. Fluorescence due to this exogenous addition of Ca2+ returned to base line at a slower rate in oocytes expressing CRT (Fig. 6B). To assay more specifically Ca2+ uptake into the intracellular stores, we compared the ATP-dependent 45Ca2+ uptake into microsomes isolated either from cells overexpressing CRT or from control cells. At 3 min, the time that the microsomes reach 50% of their total ATP-dependent 45Ca2+ uptake (33), we found a trend toward lower 45Ca2+ accumulation in microsomes from cells overexpressing CRT (Fig. 6B, p < 0.06). Together with the Ca2+ injections experiments, these last results suggest that CRT overexpression slows the rate of Ca2+ uptake into filled stores. In contrast, our data with the Ca2+ waves suggest that CRT does not measurably affect the rate of Ca2+ reuptake into InsP3-depleted stores. Our results are thus compatible with a previous report of CRT inhibiting the ER Ca2+ ATPase (55) but further suggest that this inhibition can be overcome when [Ca2+]ER decreases. Overall, these data do not support our alternative hypothesis that CRT reduces the InsP3-induced decline in [Ca2+]ER by accelerating Ca2+ reuptake/extrusion.

CRT Increases Cellular and Microsomal Ca2+-binding Capacity-- If CRT increases neither the magnitude of IICR nor the rate at which Ca2+ is retrieved back into the ER, then CRT could attenuate the InsP3-induced decrease in [Ca2+]ER simply by increasing the Ca2+-buffering capacity of the store; with more Ca2+ to start with, more Ca2+ should remain in the stores following InsP3 stimulation. To measure the impact of CRT overexpression on cellular Ca2+ content, we incubated oocytes with 45Ca2+ for 72 h, a time sufficient for the isotope to equilibrate across the Ca2+-binding compartments of the cell; 45Ca2+-related counts were 52 ± 14% higher in cells expressing CRT than they were in control cells (84 cell pairs from five different frogs, p < 0.02). Microsomes purified from groups of 10 CRT-expressing oocytes had 45Ca2+-related counts that were 59.3 ± 10% greater than controls (n = 4, p < 0.007). These data indicate that CRT overexpression increases whole cell and microsomal Ca2+ content and thus support the notion that CRT acts as a high capacity Ca2+ buffer in vivo. Because 80% of the ionomycin-releasable Ca2+ in these microsomes is InsP3-sensitive (33), these data further suggest that CRT levels can influence the capacity of the InsP3-sensitive Ca2+ pools of the oocyte.

High Capacity Ca2+-binding Domain of CRT Is Required to Prevent InsP3-induced Store Depletion and to Reduce IICI-- To probe the relationship between Ca2+-buffering properties of CRT and its ability to curb the InsP3-induced decrease in [Ca2+]ER, we deleted the C-terminal domain, or C-domain (CRT-Delta C), which is responsible for the high Ca2+-binding capacity of CRT (13). To serve as a control, and to investigate the alternative possibility that CRT could regulate the InsP3-induced Ca2+ signal by sensing a decrease in [Ca2+]ER (53), we also made a mutant lacking the P-domain (CRT-Delta P), which contains the only high affinity Ca2+-binding site of CRT (13). Successful expression of both deletion mutants was confirmed by Western blotting (Fig. 1, 3rd and 4th lanes).

At isotopic equilibrium, whole oocytes or microsomes extracted from oocytes expressing CRT-Delta C had 45Ca2+-related counts that were no different from controls (respectively 103 ± 8% (25 cell pairs) and 91 ± 6% (n = 3) of controls (100%)). In contrast, oocytes or microsomes from oocytes expressing CRT-Delta P had greater 45Ca2+ counts than did controls (respectively, 148 ± 13% (25 cell pairs, p < 0.004) and 174 ± 14% (n = 3, p < 0.01) of controls (100%)) (Fig. 7A). Thus, CRT-Delta P increased cellular and microsomal Ca2+-binding capacity to an extent similar to that observed with wild-type CRT. These results confirm that it is the C-domain that confers on CRT the ability to bind large quantities of Ca2+. Because this additional Ca2+ binds to the C-domain with low affinity (Kd ~2 mM), it should therefore be readily available for release into the cytosol upon opening of the InsP3R. Yet, CRT overexpression did not affect the elevations in [Ca2+]i due to IICR. Thus, additional releasable Ca2+ appears to have little impact on the magnitude of IICR in cells that already own substantial intracellular Ca2+ reserves.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   The C-domain mediates the functional effects of CRT. The consequence of overexpressing either full-length CRT, CRT-Delta P, or CRT-Delta C on 45Ca2+ uptake into whole cells (filled bars) or microsomes (open bars), expressed as a percent of control values (A); the InsP3-induced decrease in [Ca2+]ER, expressed as a percent decrease from the base-line 535/485 emission ratio of 3er (B); and the magnitude of the Ca2+-gated Cl- current due to IICR (closed bars) or IICI (hatched bars), expressed as a percent of control values (C). Asterisk indicates statistically significant difference (p < 0.01). Note that CRT-Delta P, but not CRT-Delta C, matches the ability of CRT to increase the cellular and microsomal Ca2+-binding capacity (A), prevent the InsP3-induced decline in [Ca2+]ER (B), and the [Ca2+]i elevations due to IICI (C).

The InsP3-induced decline in the 535/485 emission ratio of 3er was smaller in cells co-expressing CRT-Delta P than it was either in cells co-expressing CRT-Delta C (2.6 ± 0.9% versus 8.3 ± 1.4% decline, respectively, n = 11 pairs, p < 0.002) or in control cells (7.9 ± 0.8%, n = 11) (Fig. 7B). As shown in Fig. 7C, CRT-Delta P reduced the Cl- currents due to Ca2+ influx, whereas CRT-Delta C did not; neither protein changed the magnitude of the initial Cl- current due to intracellular Ca2+ release. Taken together, these data indicate that CRT relies on the C-domain both to blunt the InsP3-induced decline in [Ca2+]ER and to reduce the [Ca2+]i elevations due to IICI.

CRT Does Not Prevent Thapsigargin-induced Store Depletion from Fully Activating Ca2+ Influx-- If CRT acts primarily as a Ca2+ buffer to reduce Ca2+ influx, then a prolonged depletion of the Ca2+ stores should eventually lead to a full activation of Ca2+ influx. To test this hypothesis, we incubated oocytes with the Ca2+-ATPase inhibitor thapsigargin for 3 h (42), and we directly measured the resulting whole cell Ca2+ influx current according to the protocol of Yao and Tsien (43). As the tracings in Fig. 8A exemplify, the magnitude of the thapsigargin-induced Ca2+ influx current in cells overexpressing CRT was similar to that of controls (aggregate data for 7 cell pairs shown in Fig. 8B). Experiments with 3er-expressing oocytes confirmed that thapsigargin exposure decreases [Ca2+]ER to a similar extent in control and in CRT-expressing cells (Fig. 8C). By demonstrating that store depletion can still fully stimulate Ca2+ influx in cells overexpressing CRT, these data further support the hypothesis that CRT controls InsP3-induced Ca2+ influx by buffering [Ca2+]ER.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 8.   Thapsigargin decreases [Ca2+]ER and fully activates Ca2+ influx in CRT-expressing cells. A and B, following thapsigargin exposure, an inward current (downward deflection) is induced by switching the divalent cation in the bath solution from Mg2+ (70 mM) to Ca2+ (70 mM) (bar in A). Note that this current is of similar magnitude in control (left tracing in A, closed bar in B) and in CRT-expressing oocytes (right tracing in A, open bar in B); C, thapsigargin induced a similar decline in the 535/485 fluorescence ratio of 3er in control (closed bar, n = 10) and CRT-expressing oocytes (open bar, n = 12).

In summary, our results establish that an increase in calreticulin levels can reduce the InsP3-induced decline in [Ca2+]ER, thereby confirming the proposal originally put forth by Pozzan and co-workers (26, 28). The experimental results also link the high Ca2+-buffering capacity of CRT to its ability both to prevent Ca2+ store depletion and to reduce Ca2+ influx. Taken together, the results directly support the notion that changing levels of CRT can alter [Ca2+]ER within ranges that are relevant to the cellular mechanisms that control InsP3-induced Ca2+ influx.

    FOOTNOTES

* This work was supported by grants from the Department of Veterans Affairs (to S. D. and R. A. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** Established Investigator at the American Heart Association. To whom correspondence should be addressed: Depts. of Medicine and Physiology, University of Maryland, 3B-185 Veterans Affairs Medical Center, 10 N. Greene St., Baltimore MD 21201. Tel.: 410-605-7000 (ext. 6449); Fax: 410-605-7957; E-mail: sdelisle@umaryland.edu.

Published, JBC Papers in Press, September 5, 2000, DOI 10.1074/jbc.M002041200

    ABBREVIATIONS

The abbreviations used are: CRT, calreticulin; CaM, calmodulin; ER, endoplasmic reticulum; [Ca2+], Ca2+ concentration; [Ca2+]i, free cytosolic [Ca2+]; [Ca2+]ER, free ER lumenal [Ca2+]; FRET, fluorescence resonance energy transfer; GFP, YFP, and CFP, green, yellow, and cyan fluorescent protein, respectively; IICI, InsP3-induced Ca2+ influx; IICR, InsP3-induced Ca2+ release; InsP3, D-myo-inositol 1,4,5-trisphosphate; InsP3R, inositol 1,4,5-trisphosphate receptor; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1. Ostwald, T. J., and MacLennan, D. H. (1974) J. Biol. Chem. 249, 974-979
2. Michalak, M., Milner, R. E., Burns, K., and Opas, M. (1992) Biochem. J. 285, 681-692
3. Mesaeli, N., Nakamura, K., Zvaritch, E., Dickie, P., Dziak, E., Krause, K. H., Opas, M., MacLennan, D. H., and Michalak, M. (1999) J. Cell Biol. 144, 857-868
4. Dedhar, S., Rennie, P. S., Shago, M., Hagestelijn, C.-Y. L., Yang, H., Filmus, J., Hawley, R. G., Bruchovsky, N., Cheng, H., Matusik, R. J., and Giguère, V. (1994) Nature 367, 480-483
5. Burns, K., Duggan, B., Atkinson, E. A., Famulski, K. S., Nemer, M., Bleacklsy, R. C., and Michalak, M. (1994) Nature 367, 476-480
6. Leung-Hagesteijn, K., Milankov, C.-Y., Michalak, M., and Wilkins, J. (1994) J. Cell Sci. 107, 589-600
7. Opas, M., Szweczenko-Pawlikowska, M., Jass, G. H., Mesaeli, N., and Michalak, M. (1996) J. Cell Biol. 135, 1-11
8. Michalak, M., Burns, K., Andrin, C., Mesaeli, N., Jass, G. H., Busaan, J. L., and Opas, M. (1996) J. Biol. Chem. 271, 29436-29445
9. Perrone, L., Tell, G., and Di Lauro, R. (1999) J. Biol. Chem. 274, 4640-4645
10. Dedhar, S. (1994) Trends Biochem. Sci. 19, 269-271
11. Coppolino, M. G., Woodside, M. J., Demaurex, N., Grinstein, S., St-Arnaud, R., and Dedhar, S. (1997) Nature 386, 843-847
12. Fadel, M. P., Dziak, E., Lo, C. M., Ferrier, J., Mesaeli, N., Michalak, M., and Opas, M. (1999) J. Biol. Chem. 274, 15085-15094
13. Krause, K.-H., and Michalak, M. (1997) Cell 88, 439-443
14. Zhang, J. X., Braakman, I., Matlack, K. E., and Helenius, A. (1997) Mol. Biol. Cell 8, 1943-1954
15. Fujino, I., Yamada, N., Miyawaki, A., Hasegawa, M., Furuichi, T., and Mikoshiba, K. (1995) Cell Tissue Res. 280, 201-210
16. Peterson, J., Ora, A., Van, P. N., and Helenius, A. (1995) Mol. Biol. Cell 6, 1173-1184
17. Nauseef, W. M., McCormick, S. J., and Goedken, M. (1998) J. Biol. Chem. 273, 7107-7111
18. Thomas, A. P., Bird, G. S., Hajnoczky, G., Robb-Gaspers, L. D., and Putney, J. W. (1996) FASEB J. 10, 1505-1517
19. Randriamampita, C., and Tsien, R. Y. (1993) Nature 364, 809-814
20. Parekh, A. B., Terlau, H., and Stühmer, W. (1993) Nature 384, 814-818
21. Patterson, R. L., van Rossum, D. B., and Gill, D. L. (1999) Cell 98, 487-499
22. Yao, Y., Ferrer-Montiel, A. V., Montal, M., and Tsien, R. Y. (1999) Cell 98, 475-485
23. Putney, J. W. (1997) Cell Calcium 21, 257-261
24. Kiselyov, K., Xu, X., Mozhayaeva, G., Kuo, T., Pessah, I., Mignery, G., Birnbaumer, L., and Muallem, S. (1998) Nature 396, 478-482
25. Ma, H.-T., Patterson, R. L., van Rossum, D. B., Birnbaumer, L., Mikoshiba, K., and Gill, D. L. (2000) Science 287, 1647-1651
26. Bastianutto, C., Clementi, E., Docazzi, F., Podini, P., De Georgi, F., Rizzutto, R., Meldolesi, J., and Pozzan, T. (1995) J. Cell Biol. 130, 847-855
27. Mery, L., Mesaeli, N., Michalak, M., Opas, M., Lew, D., and Krause, K.-H. (1996) J. Biol. Chem. 271, 9332-9339
28. Fasolato, C., Pizzo, P., and Pozzan, T. (1998) Mol. Biol. Cell 9, 1513-1522
29. Denning, G. M., Leidal, K. G., Holst, V. A., Iyer, S. S., Pearson, D. W., Clark, J. R., Nauseef, W. M., and Clark, R. A. (1997) Blood 90, 372-381
30. Swick, A. G., Janicor, M., Cheneval-Kastelic, T., McLenithan, J. C., and Lane, M. D. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 1812-1816
31. DeLisle, S., Krause, K.-H., Denning, G., Potter, B. V. L., and Welsh, M. J. (1990) J. Biol. Chem. 265, 11726-11730
32. DeLisle, S., Blondel, O., Longo, F. J., Schnabel, W. E., Bell, G. I., and Welsh, M. J. (1996) Am. J. Physiol. 270, C1255-C1261
33. Parys, J. B., Sernett, S. W., DeLisle, S., Snyder, P. M., Welsh, M. J., and Campbell, K. P. (1992) J. Biol. Chem. 267, 18776-18782
34. Moreau, M., Vilain, J. P., and Guerrier, P. (1980) Dev. Biol. 78, 201-214
35. Robinson, K. R. (1985) Dev. Biol. 109, 504-508
36. Han, J. K., and Nuccitelli, R. (1990) J. Cell Biol. 110, 1103-1110
37. Parker, I., and Miledi, R. (1987) Proc. R. Soc. Lond. Ser. B Biol. Sci. 231, 27-36
38. Takahashi, T., Neher, E., and Sakmann, B. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 5063-5067
39. Miledi, R., and Parker, I. (1989) J. Physiol. (Lond.) 415, 189-210
40. Brooker, G., Seki, T., Croll, D., and Wahlestedt, C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2813-2817
41. Picard, A., Cavadore, J.-C., Lory, P., Bernengo, J.-C., Ojeda, C., and Dorée, M. (1990) Science 247, 327-329
42. Petersen, C. C. H., and Berridge, M. J. (1994) J. Biol. Chem. 269, 32246-32253
43. Yao, Y., and Tsien, R. Y. (1997) J. Gen. Physiol. 109, 703-715
44. Miyawaki, A., Liopis, J., Helm, R., McCaffery, J. M., Aeams, J. A., Ikura, M., and Tsien, R. Y. (1997) Nature 388, 882-887
45. Lipp, P., and Niggli, E. (1993) Cell Calcium 14, 359-372
46. DeLisle, S., and Welsh, M. J. (1992) J. Biol. Chem. 267, 7963-7966
47. Parys, J. B., McPherson, S. M., Mathews, L., Campbell, K. P., and Longo, F. J. (1994) Dev. Biol. 161, 466-476
48. Parker, I., and Miledi, F. R. S. (1986) Proc. R. Soc. Lond. Ser. B Biol. Sci. 228, 307-315
49. Gillo, B., Lass, Y., Nadler, E., and Oron, Y. (1987) J. Physiol. (Lond.) 392, 349-361
50. Snyder, P. M., Krause, K.-H., and Welsh, M. J. (1988) J. Biol. Chem. 263, 11048-11051
51. Hartzell, H. C. (1996) J. Gen. Physiol. 108, 157-175
52. DeLisle, S., Marksberry, E. W., Bonnett, C., Jenkins, D. J., Potter, B. V. L., Takahashi, M., and Tanzawa, K. (1997) J. Biol. Chem. 272, 9956-9961
53. Camacho, P., and Lechleiter, J. D. (1995) Cell 82, 765-771
54. Lechleiter, J. D., and Clapham, D. E. (1992) Cell 69, 283-294
55. John, L. M., Lechleiter, J. D., and Camacho, P. (1998) J. Cell Biol. 142, 963-973


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Hayashida, Y. Urata, E. Muroi, T. Kono, Y. Miyata, K. Nomata, H. Kanetake, T. Kondo, and Y. Ihara
Calreticulin Represses E-cadherin Gene Expression in Madin-Darby Canine Kidney Cells via Slug
J. Biol. Chem., October 27, 2006; 281(43): 32469 - 32484.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Ihara, Y. Urata, S. Goto, and T. Kondo
Role of calreticulin in the sensitivity of myocardiac H9c2 cells to oxidative stress caused by hydrogen peroxide
Am J Physiol Cell Physiol, January 1, 2006; 290(1): C208 - C221.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
Z. Wilczynska, K. Happle, A. Muller-Taubenberger, C. Schlatterer, D. Malchow, and P. R. Fisher
Release of Ca2+ from the Endoplasmic Reticulum Contributes to Ca2+ Signaling in Dictyostelium discoideum
Eukaryot. Cell, September 1, 2005; 4(9): 1513 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Mery, F. Aimond, C. Menard, K. Mikoshiba, M. Michalak, and M. Puceat
Initiation of Embryonic Cardiac Pacemaker Activity by Inositol 1,4,5-Trisphosphate-dependent Calcium Signaling
Mol. Biol. Cell, May 1, 2005; 16(5): 2414 - 2423.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. Treves, C. Franzini-Armstrong, L. Moccagatta, C. Arnoult, C. Grasso, A. Schrum, S. Ducreux, M. X. Zhu, K. Mikoshiba, T. Girard, et al.
Junctate is a key element in calcium entry induced by activation of InsP3 receptors and/or calcium store depletion
J. Cell Biol., August 16, 2004; 166(4): 537 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Arnaudeau, M. Frieden, K. Nakamura, C. Castelbou, M. Michalak, and N. Demaurex
Calreticulin Differentially Modulates Calcium Uptake and Release in the Endoplasmic Reticulum and Mitochondria
J. Biol. Chem., November 22, 2002; 277(48): 46696 - 46705.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Ding, B. Albrecht, R. E. Kelley, N. Muthusamy, S.-J. Kim, R. A. Altschuld, and M. D. Lairmore
Human T-Cell Lymphotropic Virus Type 1 p12I Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells
J. Virol., September 11, 2002; 76(20): 10374 - 10382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Clark, S.-L. Li, D. W. Pearson, K. G. Leidal, J. R. Clark, G. M. Denning, R. Reddick, K.-H. Krause, and A. J. Valente
Regulation of Calreticulin Expression during Induction of Differentiation in Human Myeloid Cells. EVIDENCE FOR REMODELING OF THE ENDOPLASMIC RETICULUM
J. Biol. Chem., August 23, 2002; 277(35): 32369 - 32378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kageyama, Y. Ihara, S. Goto, Y. Urata, G. Toda, K. Yano, and T. Kondo
Overexpression of Calreticulin Modulates Protein Kinase B/Akt Signaling to Promote Apoptosis during Cardiac Differentiation of Cardiomyoblast H9c2 Cells
J. Biol. Chem., May 24, 2002; 277(22): 19255 - 19264.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
S. Persson, S. E. Wyatt, J. Love, W. F. Thompson, D. Robertson, and W. F. Boss
The Ca2+ Status of the Endoplasmic Reticulum Is Altered by Induction of Calreticulin Expression in Transgenic Plants
Plant Physiology, July 1, 2001; 126(3): 1092 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page